Search Results - Eugenia A. Isupova

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Homocystinuria: Literature Review and Clinical Case Description by Natalia V. Buchinskaya, Eugenia A. Isupova, Mikhail M. Kostik

    Published 2019-09-01

    Homocystinuria is rare autosomal-recessive monogenic disorder associated with disturbance of methionine metabolism due to liver enzyme cystathionine--synthetase (CBS) deficit. That in turn causes elevated concentration of homocystein and its metabolites in blood and urine. The main clinical manifest...

    Full description

    Get full text
    Article
  2. 2

    The Use of Tocilizumab in 40 Patients With Polyarticular Juvenile Idiopathic Arthritis: the Results of a Retrospective Study by Mikhail M. Kostik, Irina A. Chikova, Eugenia A. Isupova, Margarita E. Dubko, Vera V. Masalova, Tatyana S. Likhacheva, Ludmila S. Snegireva, Ekaterina V. Gaidar, Olga V. Kalashnikova, Vyacheslav G. Chasnyk

    Published 2017-06-01

    The issue of a therapy of children with juvenile idiopathic arthritis (JIA) with intolerance or insufficient effectiveness of methotrexate remains actual.Objective: Our aim was to study the efficacy and safety of tocilizumab in patients with polyarticular JIA.Methods. In a retrospective study, we st...

    Full description

    Get full text
    Article
  3. 3

    DIFFERENTIATED APPROACH TO NON-BACTERIAL OSTEOMYELITIS TREATMENT IN CHILDREN: THE RETROSPECTIVE STUDY RESULTS by Mikhail M. Kostik, Olga L. Kopchak, Irina A. Chikova, Eugenia A. Isupova, Vera V. Masalova, Margarita F. Dubko, Ludmila S. Snegireva, Olga V. Kalashnikova, Alexandr Y. Mushkin, Vyacheslav G. Chasnyk

    Published 2016-11-01

    Differentiated Approach to Non-Bacterial Osteomyelitis Treatment in Children: the Retrospective Study Results Background. Low efficacy of the therapy of children with non-bacterial osteomyelitis remains a topical problem of modern pediatrics and rheumatology. Objective: Our aim was to assess the eff...

    Full description

    Get full text
    Article
  4. 4

    ETANERCEPT TREATMENT RESULTS IN CHILDREN WITH NON-SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: REMISSION, RECRUDESCENCE, AND ADVERSE EVENTS. RETROSPECTIVE COHORT STUDY by Mikhail M. Kostik, Irina A. Chikova, Eugenia A. Isupova, Maria N. Likhacheva, Tatyana S. Likhacheva, Margaruta F. Dubko, Vera V. Masalova, Ludmila S. Snegireva, Ekaterina V. Gaidar, Olga V. Kalashnikova, Vyacheslav G. Chasnyk

    Published 2018-05-01

    Background. Etanercept is a biological drug most commonly used in patients with juvenile idiopathic arthritis (JIA). The results of its use are showed in local studies.Objective. Our aim was to evaluate the efficacy and safety of the use of etanercept in children with non-systemic JIA, to determine...

    Full description

    Get full text
    Article
  5. 5

    DIFFERENTIAL DIAGNOSIS OF SYSTEMIC-ONSET JUVENILE ARTHRITIS AND RHEUMATIC MASKS OF ONCOHEMATOLOGICAL DISEASES: A RETROSPECTIVE COHORT STUDY by Mikhail M. Kostik, Eugenia A. Isupova, Ekaterina A. Shilova, Ilya S. Avrusin, Yuri Y. Korin, Irina A. Chikova, Margarita F. Dubko, Vera V. Masalova, Ludmila S. Snegireva, Tatyana L. Kornishina, Ekaterina V. Gaidar, Olga V. Kalashnikova, Tatyana F. Panova, Olga L. Kopchak, Vyacheslav G. Chasnyk

    Published 2017-07-01

    Background. Patients with malignant oncohematological diseases (OHD) may have such symptoms as fever, lymphadenopathy, hepatosplenomegaly,  joint pain, arthritis, elevated erythrocyte sedimentation rate (ESR) and C-reactive  protein (CRP) concentration, anemia that require differentiation from clini...

    Full description

    Get full text
    Article